Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7493 p307
15 March 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• Category M medicines
• Community pharmacy (3)
• Primary care contracts
• 100-hour pharmacies
• PCT commissioning
• Prescription charges
• Medicines use reviews
• Dispensing
• Minor ailment scheme
• Adverse drug reactions
• Asthma management (2)
• Non-practising status
• The Society


Letters to the Editor

Dispensing

Take back work from specialist laboratories

Mr L. J. Cope MRPharmS

The question of extemporaneous dispensing is not difficult to address.

In the early 1990s I worked in a pharmacy where the local GP held a clinic in dermatology at the local hospital. In a single morning we would be called upon to dispense up to six extemporaneous ointments, creams and lotions. Most of these were compounded on a “slab” which had, in a previous existence, been the side window of a Mini. We made menthol and camphor in white soft paraffin and numerous bottles of sodium bicarbonate ear drops.

Early this century I was still making batches of L-thyroxine 10mg powders for an infant and, until I had to stop working, due to a stroke, I regularly made menthol in aqueous cream.

If the profession took a step back from the desire to be “second tier” doctors, spent more time at the bench, rather than carrying out medicines use reviews while the patients were waiting to have their prescriptions checked, the standing of pharmacy would be enhanced, and the recently qualified computer-literate “whizz-kids” could really practise their art.

I realise that some work will need to be handled by specialist laboratories, but most work carried out by them can safely and efficiently be done in a dispensary, by a competent pharmacist or dispenser. This would benefit the patient, and, in the long run, the cash-strapped NHS.

Leslie Cope
Walsall, West Midlands

Send your letter to The Editor

Previous Topic (Medicines use reviews)
Next Topic (Minor ailment scheme)

Back to Top


©The Pharmaceutical Journal